BeOne registers two trials: first-in-human BON-107 study and myeloma quadruplet with sonrotoclaxNov 12Weekly roundup, 2 itemsBeiGenesonrotoclax
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
GSK's Benlysta label updated by FDA; Phase 2a NASH trial posts resultsOct 30Weekly roundup, 10 itemsaletekitugAmgenUpdated
C4 Therapeutics reports Q2 2026 results, cemsidomide trials on track for 2027 dataAug 11Quarterly updateC4 Therapeutics, Inc.cemsidomide
Bristol Myers Squibb raises 2026 guidance, cites pipeline progress across four programsJul 30Quarterly updateBristol Myers Squibbluspatercept
Karuna/BMS opens Phase 3 KarXT relapse prevention trial in schizophreniaJul 7Weekly roundup, 2 itemsBristol Myers Squibbpomalidomide